Elanco Animal Health Incorporated
DE ˙ DB ˙ US28414H1032
20,80 € ↑0,04 (0,19%)
2026-06-05
DEL PRIS
SecurityDE:5EA / Elanco Animal Health Incorporated
InstitutionAmeriprise Financial Inc
Latest Disclosed Ownership663,096 shares
Latest Disclosed Value $ 15,864,179
Ameriprise Financial Inc reports 6.53% increase in ownership of 5EA / Elanco Animal Health Incorporated

On May 15, 2026 - Ameriprise Financial Inc filed a 13F-HR form disclosing ownership of 663,096 shares of Elanco Animal Health Incorporated (DE:5EA) valued at $13,523,843 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 622,450 shares of Elanco Animal Health Incorporated. This represents a change in shares of 6.53% during the quarter. The current value of the position is $13,792,397 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 663,096 40,646 6.53 15,864 12.62 0.0007
2026-02-17 2025-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 622,450 -5,128 -0.82 14,086 11.44 0.0006
2025-11-14 2025-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 627,578 437,958 230.97 12,640 366.94 0.0029
2025-08-14 2025-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 189,620 51,123 36.91 2,708 86.18 0.0007
2025-05-14 2025-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 138,497 41,124 42.23 1,454 23.32 0.0004
2025-02-14 2024-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 97,373 54,581 127.55 1,179 87.74 0.0003
2024-11-14 2024-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 42,792 -725,494 -94.43 629 -94.34 0.0002
2024-08-14 2024-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 768,286 -155,080 -16.80 11,086 -26.25 0.0030
2024-05-15 2024-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 923,366 13,009 1.43 15,032 10.82 0.0041
2024-02-14 2023-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 910,357 -14,497 -1.57 13,564 30.50 0.0041
2023-11-14 2023-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 924,854 47,325 5.39 10,395 17.75 0.0034
2023-08-14 2023-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 877,529 -166,081 -15.91 8,828 -10.01 0.0028
2023-05-22 2023-03-31 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 1,043,610 -1,321 -0.13 9,810 -23.18 0.0032
2023-05-15 2023-03-31 13F 8X8 COM 28414H103 1,043,610 -1,321 9,810 0.0006
2023-02-14 2022-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,044,931 84,178 8.76 12,769 7.09 0.0044
2022-11-14 2022-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 960,753 335,408 53.64 11,924 -2.87 0.0044
2022-08-15 2022-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 625,345 47,374 8.20 12,276 -18.48 0.0043
2022-05-16 2022-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 577,971 -189,307 -24.67 15,058 -30.76 0.0044
2022-02-14 2021-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 767,278 -2,058,422 -72.85 21,746 -75.87 0.0060
2021-11-15 2021-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 2,825,700 -433,553 -13.30 90,125 -22.10 0.0288
2021-08-16 2021-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 3,259,253 296,323 10.00 115,694 34.12 0.0358
2021-05-17 2021-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 2,962,930 157,766 5.62 86,263 0.37 0.0287
2021-02-12 2020-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 2,805,164 889,777 46.45 85,947 60.97 0.0305
2020-11-16 2020-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,915,387 1,148,235 149.68 53,394 224.48 0.0217
2020-08-14 2020-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 767,152 -53,238 -6.49 16,455 -10.41 0.0070
2020-05-15 2020-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 820,390 740,381 925.37 18,368 679.63 0.0096
2020-02-14 2019-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 80,009 -1,273,954 -94.09 2,356 -93.46 0.0010
2019-11-14 2019-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,353,963 -503,830 -27.12 36,002 -42.66 0.0161
2019-08-14 2019-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,857,793 70,192 3.93 62,787 9.52 0.0281
2019-05-15 2019-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,787,601 218,801 13.95 57,328 15.90 0.0264
2019-02-14 2018-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,568,800 -66,500 -4.07 49,464 -13.16 0.0247
2018-11-14 2018-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,635,300 1,635,300 56,963 0.0199
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.